Table 3.
Correlates of Abnormal Histology
| Histology results | |||
|---|---|---|---|
| Characteristic | AIN I (n = 13) | AIN II-III or SCCIS (n = 18) | p Value |
| Anal intercourse | 0.066 | ||
| Yes | 2 (18.2) | 9 (81.8) | |
| No | 9 (52.9) | 8 (47.1) | |
| History of STD | 0.833 | ||
| Yes | 6 (40.0) | 9 (60.0) | |
| No | 7 (43.8) | 9 (56.3) | |
| Number of sex partners in the last 12 months | 0.469 | ||
| 0 | 1 (33.33) | 2 (66.7) | |
| 1–3 | 9 (50.0) | 9 (50.0) | |
| 4 or more partners | 2 (25.0) | 6 (75.0) | |
| On ARV therapy | 0.069 | ||
| Yes | 13 (48.1) | 14 (51.9) | |
| No | 0 (0.0) | 4 (100.0) | |
| CD4 count (cells/mm3) | 0.031 | ||
| < 200 | 4 (50.0) | 4 (50.0) | |
| 200–350 | 2 (16.7) | 10 (83.3) | |
| 350–500 | 3 (42.9) | 4 (57.1) | |
| > 500 | 4 (100.0) | 0 (0.0) | |
| Viral load (copies/mL) | 0.005 | ||
| < 75 | 9 (81.8) | 2 (18.2) | |
| 75–4000 | 1 (10.0) | 9 (90.0) | |
| > 4000 | 0 (0.0) | 2 (100.0) | |
| > 10000 | 3 (37.5) | 5 (62.5) | |
STD, sexually transmitted diseases; ARV, antiretroviral therapy; AIN, anal intraepithelial neoplasia; SCCIS, squamous cell carcinoma in situ.